Endovascular interventions for acute pulmonary embolism

Perspectives in Vascular Surgery and Endovascular Therapy

Volumn 22, Issue 3, 2010, Pages 171-182

  Lin, Peter H ^a   Huiting Chen, ^a   Bechara, Carlos F ^a   Kougias, Panagiotis ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

catheter directed thrombolysis; catheterizations; deep vein thrombosis; mechanical thrombectomy; pulmonary embolism; thrombolytic therapy; ultrasound accelerated thrombolysis

Indexed keywords

ACUTE DISEASE; ARTICLE; CATHETER; CATHETERIZATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; EMBOLECTOMY; ENDOVASCULAR SURGERY; FIBRINOLYTIC THERAPY; FILTER; HUMAN; LUNG EMBOLISM; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT OUTCOME; ULTRASOUND;

ACUTE DISEASE; CATHETERIZATION; EMBOLECTOMY; ENDOVASCULAR PROCEDURES; EQUIPMENT DESIGN; EVIDENCE-BASED MEDICINE; HUMANS; PULMONARY EMBOLISM; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; ULTRASONIC THERAPY; VENA CAVA FILTERS;

EID: 78650207926     PISSN: 15310035     EISSN: 15310027     Source Type: Journal    
DOI: 10.1177/1531003510379880     Document Type: Article

References (91)

1. Hamilton-Craig CR, McNeil K., Dunning J., Walters DL, Slaughter R., Kermeen F. Treatment options and strategies for acute severe pulmonary embolism. Intern Med J. 2008 ; 38: 657-667.
2. Zamanian RT, Gould MK Effectiveness and cost effectiveness of thrombolysis in patients with acute pulmonary embolism. Curr Opin Pulm Med. 2008 ; 14: 422-426.
3. Goldhaber SZ, Visani L., De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999 ; 353: 1386-1389.
4. Vedantham S. Interventional approaches to acute venous thromboembolism. Semin Respir Crit Care Med. 2008 ; 29: 56-65.
5. Ferreira G., Carson JL Clinical prediction rules for the diagnosis of pulmonary embolism. Am J Med. 2002 ; 113: 337-338.
6. Carson JL, Kelley MA, Duff A., et al. The clinical course of pulmonary embolism. N Engl J Med. 1992 ; 326: 1240-1245.
7. Wood KE A history of pulmonary embolism and deep venous thrombosis. Crit Care Clin. 2009 ; 25: 115-131, viii.
8. Kuo WT, van den Bosch MA, Hofmann LV, Louie JD, Kothary N., Sze DY Catheter-directed embolectomy, fragmentation, and thrombolysis for the treatment of massive pulmonary embolism after failure of systemic thrombolysis. Chest. 2008 ; 134: 250-254.
9. Douma RA, Kamphuisen PW Thrombolysis for pulmonary embolism and venous thrombosis: is it worthwhile ? Semin Thromb Hemost. 2007 ; 33: 821-828.
10. Segal JB, Streiff MB, Hofmann LV, Thornton K., Bass EB Management of venous thromboembolism: a systematic review for a practice guideline. Ann Intern Med. 2007 ; 146: 211-222.
11. Goldhaber SZ Percutaneous mechanical thrombectomy for massive pulmonary embolism: improve safety and efficacy by sharing information. Catheter Cardiovasc Interv. 2007 ; 70: 807-808.
12. Goldhaber SZ Percutaneous mechanical thrombectomy for acute pulmonary embolism: a double-edged sword. Chest. 2007 ; 132: 363-365.
13. Goldhaber SZ Advanced treatment strategies for acute pulmonary embolism, including thrombolysis and embolectomy. J Thromb Haemost. 2009 ; 7 (suppl 1). 322-327.
14. Konstantinides S. Should thrombolytic therapy be used in patients with pulmonary embolism ? Am J Cardiovasc Drugs. 2004 ; 4: 69-74.
15. Konstantinides SV Massive pulmonary embolism: what level of aggression ? Semin Respir Crit Care Med. 2008 ; 29: 47-55.
16. Jerjes-Sanchez C., Ramirez-Rivera A., de Lourdes Garcia M., et al. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial. J Thromb Thrombolysis. 1995 ; 2: 227-229.
17. Hume M. Thrombolysis of the experimental radioactive pulmonary embolus: its demonstration with the use of several agents. N Engl J Med. 1961 ; 264: 471-475.
18. Agnelli G., Becattini C., Kirschstein T. Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis. Arch Intern Med. 2002 ; 162: 2537-2541.
19. Torbicki A., Perrier A., Konstantinides S., et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2008 ; 29: 2276-2315.
20. Chechi T., Vecchio S., Spaziani G., et al. Rheolytic thrombectomy in patients with massive and submassive acute pulmonary embolism. Catheter Cardiovasc Interv. 2009 ; 73: 506-513.
21. Spies C., Khandelwal A., Smith TH, Jolly N., Kavinsky CJ Percutaneous mechanical thrombectomy for massive pulmonary embolism using a conservative treatment strategy. J Interv Cardiol. 2008 ; 21: 566-571.
22. Kucher N., Goldhaber SZ Mechanical catheter intervention in massive pulmonary embolism: proof of concept. Chest. 2008 ; 134: 2-4.
23. Margheri M., Vittori G., Vecchio S., et al. Early and long-term clinical results of AngioJet rheolytic thrombectomy in patients with acute pulmonary embolism. Am J Cardiol. 2008 ; 101: 252-258.
24. Myat A., Ahsan A. Percutaneous mechanical thrombectomy for the treatment of acute massive pulmonary embolism: case report. Thromb J. 2007 ; 5: 20.
25. Casazza F., Roncon L., Greco F. Pulmonary embolism: treatment of the acute episode. Ital Heart J. 2005 ; 6: 818-823.
26. Biederer J., Schoene A., Reuter M., Heller M., Muller-Hulsbeck S. Suspected pulmonary artery disruption after transvenous pulmonary embolectomy using a hydrodynamic thrombectomy device: clinical case and experimental study on porcine lung explants. J Endovasc Ther. 2003 ; 10: 99-110.
27. Goldhaber SZ The current role of thrombolytic therapy for pulmonary embolism. Semin Vasc Surg. 2000 ; 13: 217-220.
28. Meyer G., Brenot F., Pacouret G., et al. Subcutaneous low-molecular-weight heparin fragmin versus intravenous unfractionated heparin in the treatment of acute non massive pulmonary embolism: an open randomized pilot study. Thromb Haemost. 1995 ; 74: 1432-1435.
29. Simonneau G., Sors H., Charbonnier B., et al. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire. N Engl J Med. 1997 ; 337: 663-669.
30. Arcasoy SM, Kreit JW Thrombolytic therapy of pulmonary embolism: a comprehensive review of current evidence. Chest. 1999 ; 115: 1695-1707.
31. Uflacker R. Interventional therapy for pulmonary embolism. J Vasc Interv Radiol. 2001 ; 12: 147-164.
32. Kuo WT, Gould MK, Louie JD, Rosenberg JK, Sze DY, Hofmann LV Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques. J Vasc Interv Radiol. 2009 ; 20: 1431-1440.
33. Lin PH, Annambhotla S., Bechara CF, et al. Comparison of percutaneous ultrasound-accelerated thrombolysis versus catheter-directed thrombolysis in patients with acute massive pulmonary embolism. Vascular. 2009 ; 17 (suppl 3). S137 - S147.
34. Todd JL, Tapson VF Thrombolytic therapy for acute pulmonary embolism: a critical appraisal. Chest. 2009 ; 135: 1321-1329.
35. Skaf E., Beemath A., Siddiqui T., Janjua M., Patel NR, Stein PD Catheter-tip embolectomy in the management of acute massive pulmonary embolism. Am J Cardiol. 2007 ; 99: 415-420.
36. Kearon C., Kahn SR, Agnelli G., Goldhaber S., Raskob GE, Comerota AJ Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 ; 133: 454S - 545S. (Pubitemid 351892971)
37. Greenfield LJ, Bruce TA, Nichols NB Transvenous pulmonary embolectomy by catheter device. Ann Surg. 1971 ; 174: 881-886.
38. Gulba DC, Schmid C., Borst HG, Lichtlen P., Dietz R., Luft FC Medical compared with surgical treatment for massive pulmonary embolism. Lancet. 1994 ; 343: 576-577. (Pubitemid 124000794)
39. Tapson VF, Carroll BA, Davidson BL, et al. The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic Society. Am J Respir Crit Care Med. 1999 ; 160: 1043-1066.
40. Tapson VF, Gurbel PA, Witty LA, Pieper KS, Stack RS Pharmacomechanical thrombolysis of experimental pulmonary emboli: rapid low-dose intraembolic therapy. Chest. 1994 ; 106: 1558-1562.
41. Capstick T., Henry MT Efficacy of thrombolytic agents in the treatment of pulmonary embolism. Eur Respir J. 2005 ; 26: 864-874.
42. Harris T., Meek S. When should we thrombolyse patients with pulmonary embolism? A systematic review of the literature. Emerg Med J. 2005 ; 22: 766-771.
43. Kucher N. Catheter embolectomy for acute pulmonary embolism. Chest. 2007 ; 132: 657-663.
44. Comerota AJ, Gravett MH Iliofemoral venous thrombosis. J Vasc Surg. 2007 ; 46: 1065-1076.
45. Lin PH, Zhou W., Dardik A., et al. Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis. Am J Surg. 2006 ; 192: 782-788.
46. O'Sullivan GJ, Lohan DG, Gough N., Cronin CG, Kee ST Pharmacomechanical thrombectomy of acute deep vein thrombosis with the Trellis-8 isolated thrombolysis catheter. J Vasc Interv Radiol. 2007 ; 18: 715-724.
47. Chamsuddin A., Nazzal L., Kang B., et al. Catheter-directed thrombolysis with the Endowave system in the treatment of acute massive pulmonary embolism: a retrospective multicenter case series. J Vasc Interv Radiol. 2008 ; 19: 372-376.
48. Ouriel K., Veith FJ, Sasahara AA A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs: Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N Engl J Med. 1998 ; 338: 1105-1111.
49. Ouriel K. Randomized comparison of thrombolysis and surgery. TOPAS Investigators. Thrombolysis or Peripheral Arterial Surgery. J Vasc Interv Radiol. 1995 ; 6: 83S.
50. Fava M., Loyola S., Flores P., Huete I. Mechanical fragmentation and pharmacologic thrombolysis in massive pulmonary embolism. J Vasc Interv Radiol. 1997 ; 8: 261-266.
51. Schmitz-Rode T., Kilbinger M., Gunther RW Simulated flow pattern in massive pulmonary embolism: significance for selective intrapulmonary thrombolysis. Cardiovasc Intervent Radiol. 1998 ; 21: 199-204.
52. Schmitz-Rode T., Janssens U., Duda SH, Erley CM, Gunther RW Massive pulmonary embolism: percutaneous emergency treatment by pigtail rotation catheter. J Am Coll Cardiol. 2000 ; 36: 375-380.
53. Schmitz-Rode T., Janssens U., Schild HH, Basche S., Hanrath P., Gunther RW Fragmentation of massive pulmonary embolism using a pigtail rotation catheter. Chest. 1998 ; 114: 1427-1436.
54. Schmitz-Rode T., Janssens U., Hanrath P., Gunther RW Fragmentation of massive pulmonary embolism by pigtail rotation catheter: possible complication. Eur Radiol. 2001 ; 11: 2047-2049.
55. Haskal ZJ Mechanical thrombectomy devices for the treatment of peripheral arterial occlusions. Rev Cardiovasc Med. 2002 ; 3 (suppl 2). S45 - S52.
56. Lin PH, Okada T., Steinberg JL, et al. Rheolytic pharmacomechanical thrombectomy in experimental chronic deep vein thrombosis: effect of L-arginine on thrombogenicity and endothelial vasomotor function. World J Surg. 2007 ; 31: 664-675.
57. Chiam P., Kwok V., Johan BA, Chan C. Major pulmonary embolism treated with a rheolytic thrombectomy catheter. Singapore Med J. 2005 ; 46: 479-482.
58. Siablis D., Karnabatidis D., Katsanos K., Kagadis GC, Zabakis P., Hahalis G. AngioJet rheolytic thrombectomy versus local intrapulmonary thrombolysis in massive pulmonary embolism: a retrospective data analysis. J Endovasc Ther. 2005 ; 12: 206-214.
59. Zeni PT Jr, Blank BG, Peeler DW Use of rheolytic thrombectomy in treatment of acute massive pulmonary embolism. J Vasc Interv Radiol. 2003 ; 14: 1511-1515.
60. US Food and Drug Administration. MAUDE: Manufacturer and user facility device experience. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/ search.CFM. Accessed July 20, 2010.
61. Angiojet Xpeedior [product insert]. Minneapolis, MN: Possis Medical ; 2008.
62. Greenfield LJ Catheter pulmonary embolectomy. Chest. 1991 ; 100: 593-594.
63. Hietala SO, Greenfield LJ Percutaneous pulmonary embolectomy on the transvenous route. Ann Radiol (Paris). 1980 ; 23: 325-327.
64. Greenfield LJ Intraluminal techniques for vena caval interruption and pulmonary embolectomy. World J Surg. 1978 ; 2: 45-59.
65. Greenfield LJ, Proctor MC, Williams DM, Wakefield TW Long-term experience with transvenous catheter pulmonary embolectomy. J Vasc Surg. 1993 ; 18: 450-457 ; discussion 457-458.
66. Meyer G., Koning R., Sors H. Transvenous catheter embolectomy. Semin Vasc Med. 2001 ; 1: 247-252.
67. Popovic P., Bunc M. Massive pulmonary embolism: percutaneous emergency treatment using an aspirex thrombectomy catheter [published online ahead of print August 29, 2009 ]. Cardiovasc Intervent Radiol. doi:10.1007/s00270-009- 9693-5.
68. Horsch AD, van Oostayen J., Zeebregts CJ, Reijnen MM The Rotarex(r) and Aspirex(r) mechanical thrombectomy devices. Surg Technol Int. 2009 ; 18: 185-192.
69. Eid-Lidt G., Gaspar J., Sandoval J., et al. Combined clot fragmentation and aspiration in patients with acute pulmonary embolism. Chest. 2008 ; 134: 54-60.
70. Hoff WS, Hoey BA, Wainwright GA, et al. Early experience with retrievable inferior vena cava filters in high-risk trauma patients. J Am Coll Surg. 2004 ; 199: 869-874.
71. Linsenmaier U., Rieger J., Schenk F., Rock C., Mangel E., Pfeifer KJ Indications, management, and complications of temporary inferior vena cava filters. Cardiovasc Intervent Radiol. 1998 ; 21: 464-469.
72. Ingber S., Geerts WH Vena caval filters: current knowledge, uncertainties and practical approaches. Curr Opin Hematol. 2009 ; 16: 402-406.
73. Crowther MA Inferior vena cava filters in the management of venous thromboembolism. Am J Med. 2007 ; 120: S13 - S17.
74. Anderson RC, Bussey HI Retrievable and permanent inferior vena cava filters: selected considerations. Pharmacotherapy. 2006 ; 26: 1595-600.
75. Ray CE Jr, Mitchell E., Zipser S., Kao EY, Brown CF, Moneta GL Outcomes with retrievable inferior vena cava filters: a multicenter study. J Vasc Interv Radiol. 2006 ; 17: 1595-1604.
76. Miller GA, Sutton GC, Kerr IH, Gibson RV, Honey M. Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism. Br Heart J. 1971 ; 33: 616.
77. Dong B., Jirong Y., Liu G., Wang Q., Wu T. Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst Rev. 2006 ;(2). CD004437.
78. Wan S., Quinlan DJ, Agnelli G., Eikelboom JW Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation. 2004 ; 110: 744-749.
79. Tissue plasminogen activator for the treatment of acute pulmonary embolism. A collaborative study by the PIOPED Investigators. Chest. 1990 ; 97: 528-533.
80. Dalla-Volta S., Palla A., Santolicandro A., et al. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism: plasminogen activator Italian multicenter study 2. J Am Coll Cardiol. 1992 ; 20: 520-526.
81. Dotter CT, Rosch J., Seaman AJ, Dennis D., Massey WH Streptokinase treatment of thromboembolic disease. Radiology. 1972 ; 102: 283-290.
82. Goldhaber SZ, Haire WD, Feldstein ML, et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet. 1993 ; 341: 507-511.
83. Konstantinides S., Geibel A., Heusel G., Heinrich F., Kasper W. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med. 2002 ; 347: 1143-1150.
84. Levine M., Hirsh J., Weitz J., et al. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest. 1990 ; 98: 1473-1479.
85. Ly B., Arnesen H., Eie H., Hol R. A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism. Acta Med Scand. 1978 ; 203: 465-470. (Pubitemid 8358211)
86. Marini C., Di Ricco G., Rossi G., Rindi M., Palla R., Giuntini C. Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism: a randomized clinical trial. Respiration. 1988 ; 54: 162-173.
87. Tibbutt DA, Davies JA, Anderson JA, et al. Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonary embolism. Br Med J. 1974 ; 1: 343-347.
88. Goldhaber SZ Thrombolytic therapy for patients with pulmonary embolism who are hemodynamically stable but have right ventricular dysfunction: pro. Arch Intern Med. 2005 ; 165: 2197-2199 ; discussion 2204-2205.
89. Lee S., Song SW, Yi G., Youn YN, Yoo KJ, Chang BC Open pulmonary thromboembolectomy in patients with major pulmonary thromboembolism. Yonsei Med J. 2008 ; 49: 973-977.
90. Kucher N., Rossi E., De Rosa M., Goldhaber SZ Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch Intern Med. 2005 ; 165: 1777-1781.
91. Geibel A., Olschewski M., Zehender M., et al. Possible gender-related differences in the risk-to-benefit ratio of thrombolysis for acute submassive pulmonary embolism. Am J Cardiol. 2007 ; 99: 103-107.